{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:26:55Z","timestamp":1782484015642,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PS 178091"],"award-info":[{"award-number":["PS 178091"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008895","name":"Tertiary Education Trust Fund","doi-asserted-by":"publisher","award":["TETF\/ES\/POLY\/IMO STATE\/TSAS\/2019"],"award-info":[{"award-number":["TETF\/ES\/POLY\/IMO STATE\/TSAS\/2019"]}],"id":[{"id":"10.13039\/501100008895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008895","name":"Tertiary Education Trust Fund","doi-asserted-by":"publisher","award":["TETF\/DASTD\/UNIV\/ OWERRI\/TSAS\/2020 \/VOL.1"],"award-info":[{"award-number":["TETF\/DASTD\/UNIV\/ OWERRI\/TSAS\/2020 \/VOL.1"]}],"id":[{"id":"10.13039\/501100008895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.119070","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:07:05Z","timestamp":1769598425000},"page":"119070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dual intestinal-hepatic modulation by phenolic acids improves metabolic-dysfunction associated steatohepatitis"],"prefix":"10.1016","volume":"195","author":[{"given":"Peter U.","family":"Amadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justice O.","family":"Osuoha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy.A.","family":"Amadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esienanwan E.","family":"Efiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince C.","family":"Odika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestine E.","family":"Ekweogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chioma","family":"Ejiofor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suha J.","family":"Jarad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiamaka W.","family":"Amadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"de Courten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel N.","family":"Agomuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2026.119070_bib1","doi-asserted-by":"crossref","first-page":"C1637","DOI":"10.1152\/ajpcell.00951.2024","article-title":"Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease","volume":"328","author":"Kuchay","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2026.119070_bib2","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes","volume":"12","author":"Dua","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.biopha.2026.119070_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101882","article-title":"Pharmacotherapy of obesity: an update on the available medications and drugs under investigation","volume":"58","author":"Chakhtoura","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"27","key":"10.1016\/j.biopha.2026.119070_bib4","doi-asserted-by":"crossref","first-page":"E797","DOI":"10.1503\/cmaj.250502","article-title":"Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update","volume":"197","author":"Pedersen","year":"2025","journal-title":"CMAJ"},{"issue":"144-1","key":"10.1016\/j.biopha.2026.119070_bib5","article-title":"Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers","volume":"281","author":"Carri\u00e8re","year":"2001","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119070_bib6","first-page":"603","article-title":"Efficacy of orlistat in obese patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Mahmoud","year":"2024","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"3","key":"10.1016\/j.biopha.2026.119070_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1592\/phco.20.4.270.34882","article-title":"Orlistat, a new lipase inhibitor for the management of obesity","volume":"20","author":"Heck","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.biopha.2026.119070_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14744\/hf.2024.2024.0047","article-title":"Efficacy of orlistat for the treatment of metabolic dysfunction-associated steatotic liver disease patients: a systematic review and meta-analysis","volume":"6","author":"Ayati","year":"2025","journal-title":"Hepatol. Forum"},{"key":"10.1016\/j.biopha.2026.119070_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116432","article-title":"Bioactive compounds from nature: Antioxidants targeting cellular transformation in response to epigenetic perturbations induced by oxidative stress","volume":"174","author":"Bouyahya","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2026.119070_bib10","article-title":"Metabolism and bioavailability aspects of natural products of plant origin using mass spectrometry-based and metabolomic approaches","author":"Mikropoulou E","year":"2025","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.biopha.2026.119070_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107602","article-title":"Phenolic acids from Anisopus mannii modulates phosphofructokinase 1 to improve glycemic control in patients with type 2 diabetes: a double-blind, randomized, clinical trial","volume":"212","author":"Amadi","year":"2025","journal-title":"Pharm. Res"},{"issue":"9","key":"10.1016\/j.biopha.2026.119070_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2011.128","article-title":"Orlistat 60 mg reduces levels of visceral adipose tissue in obese individuals","volume":"8","author":"Franks","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119070_bib13","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1038\/s41591-025-03978-z","article-title":"A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults","volume":"31","author":"McGowan","year":"2025","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119070_bib14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.ijo.0801645","article-title":"Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid)","volume":"25","author":"Cavaliere","year":"2001","journal-title":"Int. J. Obes."},{"issue":"1","key":"10.1016\/j.biopha.2026.119070_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002018-200831010-00005","article-title":"Orlistat-associated adverse effects and drug interactions: a critical review","volume":"31","author":"Filippatos","year":"2008","journal-title":"Drug Saf."},{"key":"10.1016\/j.biopha.2026.119070_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1639064","article-title":"Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: an integrative perspective from molecular pathways to clinical challenges","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.biopha.2026.119070_bib17","doi-asserted-by":"crossref","first-page":"C1637","DOI":"10.1152\/ajpcell.00951.2024","article-title":"Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease","volume":"328","author":"Kuchay","year":"2025","journal-title":"Am. J. Physiol.-Cell Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119070_bib18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41366-025-01729-1","article-title":"Role of pancreatic lipase inhibition in obesity treatment: mechanisms and challenges towards current insights and future directions","volume":"49","author":"Subramaniyan","year":"2025","journal-title":"Int. J. Obes. (Lond.)"},{"issue":"11","key":"10.1016\/j.biopha.2026.119070_bib19","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1016\/j.apsb.2024.08.021","article-title":"PPAR\u03b1 affects hepatic lipid homeostasis by perturbing necroptosis signals in the intestinal epithelium","volume":"14","author":"Na","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.119070_bib20","unstructured":"Strelow J., Dewe W., Iversen P.W., et al. Mechanism of Action Assays for Enzymes. Assay Guidance Manual. Published online October 1, 2012. Accessed November 18, 2025. \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK92001\/\u3009."},{"key":"10.1016\/j.biopha.2026.119070_bib21","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.5c00164","article-title":"Primary small intestinal epithelia are physiological alternatives to the caco-2 lymphatic transport model","author":"Smith","year":"2025","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2026.119070_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tem.2023.10.002","article-title":"Mechanisms of hepatic fatty acid oxidation and ketogenesis during fasting","volume":"35","author":"Ruppert","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2026.119070_bib23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1186\/s12967-025-07232-5","article-title":"Lipid metabolism orchestrates liver regeneration: an integrated metabolic network","volume":"23","author":"Duan","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119070_bib24","unstructured":"Girish V., John S. Metabolic Dysfunction-Associated Steatotic Liver Disease (M\u0391SLD). StatPearls. Published online 2025. Accessed November 18, 2025. \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541033\/\u3009."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:39:22Z","timestamp":1778693962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":24,"alternative-id":["S0753332226001022"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119070","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual intestinal-hepatic modulation by phenolic acids improves metabolic-dysfunction associated steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119070"}}